About this policy
The comment period for the MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms DL40022 Local Coverage Determination (LCD) began on 08/01/2024 and ended on 09/15/2024. The notice period for L40022 begins on 07/03/2025 and will become effective on 08/17/2025. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.